TrialClinical trialPHN-02952026-10-08 19:00 CT
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
Source · ClinicalTrials.gov: peptide AND aging
TLDR
A recruiting trial listed on ClinicalTrials.gov will study Adapted Argentine Tango for chemotherapy-induced neuropathy in breast cancer survivors. The listing states that up to 80% of these survivors experience neuropathy and describes an intervention targeting motor control, symptoms, and treatment participation.
01—Key points
- 01The trial is recruiting; no results are reported in the excerpt.
- 02Investigators propose a noninvasive, social sensorimotor intervention using Adapted Argentine Tango.
- 03The excerpt does not mention peptides or peptide-based treatments.
Why it matters Editorial
The trial explores an intervention for a condition the listing describes as impairing quality of life and increasing fall risk, but it has no stated peptide connection.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.